查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1878910

心臟節律器市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、技術、產品類型、應用、最終用戶、地區和競爭格局分類，2020-2030年預測

Pacemaker Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Technology, By Product Type, By Applications, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球心臟節律器市場規模為51億美元，預計2030年將以4.47%的複合年成長率成長至66.3億美元。心臟心律調節器是一種植入式醫療設備，旨在產生電脈衝，從而調節異常心律。全球心臟心律調節器市場的成長主要受心血管疾病在全球範圍內日益普遍以及老年人口不斷成長的推動，因為高齡是心律不整的主要風險因素。此外，設備的微型化、電池壽命的延長以及遠端監測功能的整合等技術的不斷進步也進一步推動了市場成長。

市場概覽
預測期 2026-2030
2024年市場規模 51億美元
2030年市場規模 66.3億美元
2025-2030年複合年成長率 4.47%
成長最快的細分市場 可植入式
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球心臟節律器市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依類型（植入式、體外）
    • 依技術類型（雙腔、單腔、雙心室）
    • 依產品類型（MRI兼容型、傳統型）
    • 依應用領域（心律不整、充血性心臟衰竭、其他）
    • 依最終使用者（醫院、心臟護理中心、門診手術中心）分類
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美心臟節律器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲心臟節律器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區心臟節律器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲心臟節律器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美心臟節律器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球心臟節律器市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Medtronic PLC
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • Sorin Group
  • Abbott Laboratories Inc.
  • Edwards Lifesciences Corporation
  • B. Braun Melsungen AG
  • Osypka Medical GmbH
  • Medico SpA
  • Oscor, Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 9500

The Global Pacemaker Market, valued at USD 5.10 Billion in 2024, is projected to experience a CAGR of 4.47% to reach USD 6.63 Billion by 2030. A pacemaker is an implanted medical device designed to generate electrical impulses, thereby regulating abnormal heart rhythms. The global pacemaker market's growth is primarily driven by the increasing worldwide prevalence of cardiovascular diseases and the expanding geriatric population, as advanced age is a key risk factor for cardiac arrhythmias. Further impetus comes from continuous technological advancements, including device miniaturization, enhanced battery longevity, and integrated remote monitoring capabilities.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.10 Billion
Market Size 2030USD 6.63 Billion
CAGR 2025-20304.47%
Fastest Growing SegmentImplantable
Largest MarketNorth America

Key Market Drivers

The rising prevalence of cardiovascular diseases serves as a fundamental driver for the global pacemaker market. Cardiac conditions, particularly those involving rhythm disorders such as bradycardia, frequently necessitate pacemaker implantation to restore and maintain proper heart function. This increasing disease burden is observable globally, creating a continuous demand for advanced cardiac rhythm management solutions. According to a new study published in JACC, January 2024, 'New Study Reveals Latest Data on Global Burden of Cardiovascular Disease', global death counts attributed to cardiovascular disease rose to 19.8 million in 2022. The persistent rise in these complex conditions underscores the critical need for effective interventions, directly expanding the patient pool eligible for pacemaker therapy.

Key Market Challenges

The elevated cost of advanced pacemaker devices and associated implantation procedures presents a significant impediment to the global pacemaker market's expansion. This financial barrier directly restricts patient accessibility and affordability, particularly in regions with developing healthcare infrastructures and lower per capita income. The high upfront investment required for these medical devices, coupled with the expenses of specialized surgical procedures and ongoing follow-up care, creates a substantial economic burden for healthcare systems and individual patients alike.

Key Market Trends

The global pacemaker market is significantly influenced by the growing adoption of leadless pacemakers. These miniaturized devices, implanted directly into the heart without leads or a surgical pocket, reduce the risk of complications associated with traditional transvenous systems. For instance, a March 2024 summary by the American College of Cardiology highlighted a post-approval registry finding that Micra leadless pacemakers had a major complication rate of 4.1% at 36 months, which was significantly lower than the 8.5% observed for transvenous systems. This reduction in complications contributes to improved patient outcomes and expanded indications for leadless therapy.

Key Market Players

  • Medtronic PLC
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • Sorin Group
  • Abbott Laboratories Inc.
  • Edwards Lifesciences Corporation
  • B. Braun Melsungen AG
  • Osypka Medical GmbH
  • Medico S.p.A
  • Oscor, Inc.

Report Scope:

In this report, the Global Pacemaker Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pacemaker Market, By Type:

  • Implantable
  • External

Pacemaker Market, By Technology:

  • Dual Chamber
  • Single Chamber
  • Biventricular Chamber

Pacemaker Market, By Product Type:

  • MRI Compatible
  • Conventional

Pacemaker Market, By Applications:

  • Arrythmias
  • Congestive Heart Failure
  • Others

Pacemaker Market, By End User:

  • Hospitals
  • Cardiac Care Centers
  • Ambulatory Surgical Centers

Pacemaker Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pacemaker Market.

Available Customizations:

Global Pacemaker Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pacemaker Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Implantable, External)
    • 5.2.2. By Technology (Dual Chamber, Single Chamber, Biventricular Chamber)
    • 5.2.3. By Product Type (MRI Compatible, Conventional)
    • 5.2.4. By Applications (Arrythmias, Congestive Heart Failure, Others)
    • 5.2.5. By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers)
    • 5.2.6. By Region
    • 5.2.7. By Company (2024)
  • 5.3. Market Map

6. North America Pacemaker Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Technology
    • 6.2.3. By Product Type
    • 6.2.4. By Applications
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pacemaker Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Product Type
        • 6.3.1.2.4. By Applications
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Pacemaker Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Product Type
        • 6.3.2.2.4. By Applications
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Pacemaker Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Product Type
        • 6.3.3.2.4. By Applications
        • 6.3.3.2.5. By End User

7. Europe Pacemaker Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Technology
    • 7.2.3. By Product Type
    • 7.2.4. By Applications
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pacemaker Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Product Type
        • 7.3.1.2.4. By Applications
        • 7.3.1.2.5. By End User
    • 7.3.2. France Pacemaker Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Product Type
        • 7.3.2.2.4. By Applications
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Pacemaker Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Product Type
        • 7.3.3.2.4. By Applications
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Pacemaker Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Product Type
        • 7.3.4.2.4. By Applications
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Pacemaker Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Product Type
        • 7.3.5.2.4. By Applications
        • 7.3.5.2.5. By End User

8. Asia Pacific Pacemaker Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Technology
    • 8.2.3. By Product Type
    • 8.2.4. By Applications
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pacemaker Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Product Type
        • 8.3.1.2.4. By Applications
        • 8.3.1.2.5. By End User
    • 8.3.2. India Pacemaker Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Product Type
        • 8.3.2.2.4. By Applications
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Pacemaker Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Product Type
        • 8.3.3.2.4. By Applications
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Pacemaker Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Product Type
        • 8.3.4.2.4. By Applications
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Pacemaker Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Product Type
        • 8.3.5.2.4. By Applications
        • 8.3.5.2.5. By End User

9. Middle East & Africa Pacemaker Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Technology
    • 9.2.3. By Product Type
    • 9.2.4. By Applications
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pacemaker Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Product Type
        • 9.3.1.2.4. By Applications
        • 9.3.1.2.5. By End User
    • 9.3.2. UAE Pacemaker Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Product Type
        • 9.3.2.2.4. By Applications
        • 9.3.2.2.5. By End User
    • 9.3.3. South Africa Pacemaker Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Product Type
        • 9.3.3.2.4. By Applications
        • 9.3.3.2.5. By End User

10. South America Pacemaker Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Technology
    • 10.2.3. By Product Type
    • 10.2.4. By Applications
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pacemaker Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Product Type
        • 10.3.1.2.4. By Applications
        • 10.3.1.2.5. By End User
    • 10.3.2. Colombia Pacemaker Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Product Type
        • 10.3.2.2.4. By Applications
        • 10.3.2.2.5. By End User
    • 10.3.3. Argentina Pacemaker Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Product Type
        • 10.3.3.2.4. By Applications
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pacemaker Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic PLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Boston Scientific Corporation
  • 15.3. BIOTRONIK SE & Co. KG
  • 15.4. Sorin Group
  • 15.5. Abbott Laboratories Inc.
  • 15.6. Edwards Lifesciences Corporation
  • 15.7. B. Braun Melsungen AG
  • 15.8. Osypka Medical GmbH
  • 15.9. Medico S.p.A
  • 15.10. Oscor, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer